Production (Stage)
Claritas Pharmaceuticals, Inc.
CLAZF
$0.00
$0.000.00%
OTC PK
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Net Income | -4.72M | -5.31M | -12.03M | 4.21M | -3.62M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.24M | 5.42M | 12.87M | -3.74M | 3.95M |
| Change in Net Operating Assets | -471.00K | -509.00K | -1.44M | -782.00K | -313.00K |
| Cash from Operations | -953.00K | -405.00K | -607.00K | -309.00K | 20.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.00K | -1.00K | 5.00K | 2.00K | -5.00K |
| Cash from Investing | -1.00K | -1.00K | 5.00K | 2.00K | -5.00K |
| Total Debt Issued | 118.00K | 118.00K | 68.00K | 68.00K | 68.00K |
| Total Debt Repaid | -10.00K | -10.00K | -10.00K | -- | 0.00 |
| Issuance of Common Stock | 358.00K | 569.00K | 569.00K | 212.00K | 376.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 466.00K | 677.00K | 627.00K | 280.00K | 444.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -488.00K | 271.00K | 25.00K | -27.00K | 459.00K |